Constantine Davides
Stock Analyst at Citizens
(0.87)
# 3,959
Out of 5,179 analysts
120
Total ratings
25.23%
Success rate
-24.05%
Average return
Main Sectors:
Stocks Rated by Constantine Davides
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMN AMN Healthcare Services | Maintains: Market Outperform | $22 → $24 | $18.91 | +26.92% | 14 | Feb 23, 2026 | |
| PGNY Progyny | Upgrades: Market Outperform | $30 | $17.27 | +73.71% | 4 | Jan 20, 2026 | |
| OPCH Option Care Health | Reiterates: Market Outperform | $36 → $38 | $27.27 | +39.35% | 8 | Jan 13, 2026 | |
| EVH Evolent Health | Maintains: Market Outperform | $11 → $10 | $2.21 | +352.49% | 12 | Jan 6, 2026 | |
| HQY HealthEquity | Maintains: Market Outperform | $117 → $122 | $82.51 | +47.86% | 6 | Dec 4, 2025 | |
| PRVA Privia Health Group | Maintains: Market Outperform | $30 → $31 | $20.02 | +54.85% | 5 | Nov 7, 2025 | |
| OPRX OptimizeRx | Maintains: Market Outperform | $23 → $24 | $6.60 | +263.64% | 11 | Nov 7, 2025 | |
| WAY Waystar Holding | Initiates: Market Outperform | $48 | $23.54 | +103.91% | 1 | Sep 18, 2025 | |
| ADUS Addus HomeCare | Reiterates: Market Outperform | $150 | $95.19 | +57.58% | 4 | Jul 16, 2025 | |
| SLP Simulations Plus | Reiterates: Market Perform | n/a | $11.43 | - | 2 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $5.75 | - | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $0.40 | - | 4 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $113 | $74.75 | +51.17% | 2 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $20 → $26 | $31.28 | -16.88% | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $225 → $248 | $169.52 | +46.30% | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $21.10 | - | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $9.52 | - | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $5.25 | $0.91 | +478.96% | 3 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $0.92 | +13,486.96% | 5 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $24.55 | -38.90% | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $22.66 | -0.71% | 4 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.5 | $3.49 | +143.55% | 2 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $0.81 | +1,637.84% | 4 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $360 | $0.40 | +90,148.18% | 4 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3,240 | $1.11 | +291,791.89% | 3 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $40 | $0.74 | +5,305.41% | 2 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.20 | +2,951.88% | 2 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,400 → $800 | $1.36 | +58,723.53% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $597,600 → $298,800 | $2.70 | +11,066,566.67% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $85 | $0.15 | +58,079.33% | 2 | Sep 23, 2022 |
AMN Healthcare Services
Feb 23, 2026
Maintains: Market Outperform
Price Target: $22 → $24
Current: $18.91
Upside: +26.92%
Progyny
Jan 20, 2026
Upgrades: Market Outperform
Price Target: $30
Current: $17.27
Upside: +73.71%
Option Care Health
Jan 13, 2026
Reiterates: Market Outperform
Price Target: $36 → $38
Current: $27.27
Upside: +39.35%
Evolent Health
Jan 6, 2026
Maintains: Market Outperform
Price Target: $11 → $10
Current: $2.21
Upside: +352.49%
HealthEquity
Dec 4, 2025
Maintains: Market Outperform
Price Target: $117 → $122
Current: $82.51
Upside: +47.86%
Privia Health Group
Nov 7, 2025
Maintains: Market Outperform
Price Target: $30 → $31
Current: $20.02
Upside: +54.85%
OptimizeRx
Nov 7, 2025
Maintains: Market Outperform
Price Target: $23 → $24
Current: $6.60
Upside: +263.64%
Waystar Holding
Sep 18, 2025
Initiates: Market Outperform
Price Target: $48
Current: $23.54
Upside: +103.91%
Addus HomeCare
Jul 16, 2025
Reiterates: Market Outperform
Price Target: $150
Current: $95.19
Upside: +57.58%
Simulations Plus
Jun 18, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $11.43
Upside: -
May 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $5.75
Upside: -
Apr 28, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $0.40
Upside: -
Apr 22, 2025
Reiterates: Market Outperform
Price Target: $113
Current: $74.75
Upside: +51.17%
Feb 26, 2025
Maintains: Market Outperform
Price Target: $20 → $26
Current: $31.28
Upside: -16.88%
Feb 26, 2025
Maintains: Market Outperform
Price Target: $225 → $248
Current: $169.52
Upside: +46.30%
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $21.10
Upside: -
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $9.52
Upside: -
Jun 1, 2023
Assumes: Buy
Price Target: $5.25
Current: $0.91
Upside: +478.96%
May 16, 2023
Reiterates: Buy
Price Target: $125
Current: $0.92
Upside: +13,486.96%
May 11, 2023
Reiterates: Buy
Price Target: $15
Current: $24.55
Upside: -38.90%
May 10, 2023
Reiterates: Buy
Price Target: $23
Current: $22.66
Upside: -0.71%
May 5, 2023
Reiterates: Buy
Price Target: $8.5
Current: $3.49
Upside: +143.55%
Apr 27, 2023
Reiterates: Buy
Price Target: $14
Current: $0.81
Upside: +1,637.84%
Apr 19, 2023
Reiterates: Buy
Price Target: $360
Current: $0.40
Upside: +90,148.18%
Apr 13, 2023
Reiterates: Buy
Price Target: $3,240
Current: $1.11
Upside: +291,791.89%
Apr 3, 2023
Maintains: Buy
Price Target: $46 → $40
Current: $0.74
Upside: +5,305.41%
Mar 16, 2023
Reiterates: Buy
Price Target: $6
Current: $0.20
Upside: +2,951.88%
Sep 28, 2022
Maintains: Buy
Price Target: $1,400 → $800
Current: $1.36
Upside: +58,723.53%
Sep 28, 2022
Maintains: Buy
Price Target: $597,600 → $298,800
Current: $2.70
Upside: +11,066,566.67%
Sep 23, 2022
Maintains: Buy
Price Target: $110 → $85
Current: $0.15
Upside: +58,079.33%